Argentina, very close to the purchase of the Chinese vaccine CoronaVac in Brazil

Argentina progress in negotiations to acquire the Coronavac vaccine, of theaboratorio chino Sinovac, developed locally in Brazil by the Butantan Institute, the state of St.Paul, which has an efficiency of 78% among the 12,400 Brazilian volunteers.

This was confirmed today by Governor of San Pablo, Joao Doria, and the Director of the Butantan Institute, Dimas Covas, referring to the effectiveness of Coronavac on Brazilian soil and the start of the registration process before National Health Surveillance Agency (Anvisa).

The Butantan Institute will open a wing of its vaccine factory for its own production of CoronaVac with technology transferred from Sinovac, a Chinese private laboratory and creator of immunity.